Lp-PLA2-IN-14 is an inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2) with a pIC50 of 8.4 against recombinant human Lp-PLA2. This compound demonstrates significant potential in the study of neurodegenerative diseases, such as Alzheimer’s disease, glaucoma, and age-related macular degeneration, as well as cardiovascular conditions, including atherosclerosis. Lp-PLA2-IN-14 serves as a useful tool for researchers investigating the role of Lp-PLA2 in these pathologies.
Lp-PLA2-IN-14 is an inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2) with a pIC50 of 8.4 against recombinant human Lp-PLA2. This compound demonstrates significant potential in the study of neurodegenerative diseases, such as Alzheimer’s disease, glaucoma, and age-related macular degeneration, as well as cardiovascular conditions, including atherosclerosis. Lp-PLA2-IN-14 serves as a useful tool for researchers investigating the role of Lp-PLA2 in these pathologies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
